Cargando…

Multiple Sclerosis, Disease-Modifying Therapies and COVID-19: A Systematic Review on Immune Response and Vaccination Recommendations

Understanding the risks of COVID-19 in patients with Multiple Sclerosis (MS) receiving disease-modifying therapies (DMTs) and their immune reactions is vital to analyze vaccine response dynamics. A systematic review on COVID-19 course and outcomes in patients receiving different DMTs was conducted a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cabreira, Verónica, Abreu, Pedro, Soares-dos-Reis, Ricardo, Guimarães, Joana, Sá, Maria José
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8310076/ https://www.ncbi.nlm.nih.gov/pubmed/34358189 http://dx.doi.org/10.3390/vaccines9070773

Ejemplares similares

Cognitive Dysfunction in Multiple Sclerosis
por: Guimarães, Joana, et al.
Publicado: (2012)

Multiple Sclerosis Patient Management During the COVID-19 Pandemic: Practical Recommendations From the Portuguese Multiple Sclerosis Study Group (GEEM)
por: Cerqueira, João J., et al.
Publicado: (2021)

Pain in Portuguese Patients with Multiple Sclerosis
por: Seixas, Daniela, et al.
Publicado: (2011)

Emerging Biosensing Technologies for Neuroinflammatory and Neurodegenerative Disease Diagnostics
por: Abreu, Catarina M., et al.
Publicado: (2018)

COVID-19 vaccines and multiple sclerosis disease-modifying therapies
por: Giovannoni, Gavin, et al.
Publicado: (2021)

Initial Immunopathogenesis of Multiple Sclerosis: Innate Immune Response
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

COVID-19: The Course, Vaccination and Immune Response in People with Multiple Sclerosis: Systematic Review
por: Bazylewicz, Marcin, et al.
Publicado: (2023)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Recommendations for the Diagnosis and Treatment of Multiple Sclerosis Relapses
por: Ramo-Tello, Cristina, et al.
Publicado: (2021)

State of the Art and Future Challenges in Multiple Sclerosis Research and Medical Management: An Insight into the 5th International Porto Congress of Multiple Sclerosis
por: Sá, María José, et al.
Publicado: (2020)

Humoral and cellular immunity in convalescent and vaccinated COVID-19 people with multiple sclerosis: Effects of disease modifying therapies
por: Habek, Mario, et al.
Publicado: (2022)

Therapeutic recommendations and seasonal influenza vaccine for multiple sclerosis patients in treatment with ocrelizumab: an expert consensus
por: Filippi, Massimo, et al.
Publicado: (2021)

Argentinean consensus recommendations for the use of telemedicine in clinical practice in adult people with multiple sclerosis
por: Alonso, Ricardo, et al.
Publicado: (2022)

Impact of multiple sclerosis disease-modifying therapies on SARS-CoV-2 vaccine-induced antibody and T cell immunity
por: Sabatino, Joseph J., et al.
Publicado: (2021)

Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis
por: Beard, Katherine, et al.
Publicado: (2021)

Opinions, beliefs and knowledge of people with multiple sclerosis on COVID-19 pandemic and vaccine
por: Moniz Dionísio, Joana, et al.
Publicado: (2021)

Recommendations for cognitive screening and management in multiple sclerosis care
por: Kalb, Rosalind, et al.
Publicado: (2018)

Infectious Risk Mitigation in Patients with Multiple Sclerosis under Disease-Modifying Therapies – the Experience of a Collaborative Neurology-Infectious Diseases Approach
por: Ferro, Daniela, et al.
Publicado: (2021)

Disease Modifying Agents for Multiple Sclerosis
por: Hilas, Olga, et al.
Publicado: (2010)

Disease-modifying agents in multiple sclerosis
por: Coyle, P. K.
Publicado: (2009)

Disease Modifying Therapy in Multiple Sclerosis
por: Williams, U. E., et al.
Publicado: (2014)

Current Take on Systemic Sclerosis Patients’ Vaccination Recommendations
por: Murdaca, Giuseppe, et al.
Publicado: (2021)

Factors affecting adherence to disease-modifying therapies in multiple sclerosis: systematic review
por: Washington, Francesca, et al.
Publicado: (2021)

Relapsing–Remitting Multiple Sclerosis: Patterns of Response to Disease-Modifying Therapies and Associated Factors: A National Survey
por: Sá, Maria José, et al.
Publicado: (2014)

Diet and Multiple Sclerosis: Scoping Review of Web-Based Recommendations
por: Beckett, Jeffrey M, et al.
Publicado: (2019)

Histopathology-validated recommendations for cortical lesion imaging in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2020)

Treatment of relapsing multiple sclerosis – recommendations of the Croatian Neurological Society
por: Habek, Mario, et al.
Publicado: (2022)

Recommendations for the use of propensity score methods in multiple sclerosis research
por: Simoneau, Gabrielle, et al.
Publicado: (2022)

Teriflunomide effect on immune response to influenza vaccine in patients with multiple sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2013)

A prospective study of cellular immune response to booster COVID-19 vaccination in multiple sclerosis patients treated with a broad spectrum of disease-modifying therapies
por: Torres, Pascual, et al.
Publicado: (2023)

Tolerogenic vaccines for Multiple Sclerosis
por: Mannie, Mark D., et al.
Publicado: (2013)

Multiple Sclerosis: Overview of Disease-Modifying Agents
por: Finkelsztejn, Alessandro
Publicado: (2014)

Oral Disease-Modifying Therapies for Multiple Sclerosis
por: Kim, Woojun, et al.
Publicado: (2015)

Editorial: Disease modifying therapies in multiple sclerosis
por: Bonavita, Simona, et al.
Publicado: (2022)

Multiple Sclerosis, Disease-Modifying Therapies, and Infections
por: Langer-Gould, Annette M., et al.
Publicado: (2023)

Adherence to Disease-Modifying Therapies for Multiple Sclerosis
por: Higuera, Lucas, et al.
Publicado: (2016)

Nutrient Composition Comparison between a Modified Paleolithic Diet for Multiple Sclerosis and the Recommended Healthy U.S.-Style Eating Pattern
por: Chenard, Catherine A., et al.
Publicado: (2019)

Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

Multiple Sclerosis Patients and Disease Modifying Therapies: Impact on Immune Responses against COVID-19 and SARS-CoV-2 Vaccination
por: Golshani, Maryam, et al.
Publicado: (2022)

Immune responses to SARS‐CoV‐2 vaccination in multiple sclerosis: a systematic review/meta‐analysis
por: Gombolay, Grace Y., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_qe50m1rul3fa047vlv7seqio42